Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/26/2025

Management of Hot Flashes in Men on Androgen Deprivation Therapy

Pharmacological Management

  • The National Comprehensive Cancer Network recommends alternative hormonal options for treating hot flashes in men on ADT, including estrogen and cyproterone acetate 1, 2, 3
  • Non-hormonal pharmacological alternatives include SSRIs/SNRIs such as venlafaxine (37.5 mg/day) or paroxetine (10 mg/day) 4
  • Gabapentin (300-900 mg/day) has shown moderate efficacy in randomized controlled trials for treating hot flashes in men on ADT 1

Clinical Considerations

  • Androgens (testosterone) are contraindicated in men with advanced prostate cancer on ADT 1, 2
  • Vitamin E supplements should be used with caution as there are concerns they may increase prostate cancer risk 1

Non-Pharmacological Approaches

  • The National Comprehensive Cancer Network suggests non-pharmacological treatments that can be tried concurrently, including acupuncture 1, 2
  • Exercise/physical activity and yoga may also be effective in managing hot flashes in men on ADT 1, 2
  • Lifestyle modifications and weight loss if overweight may help alleviate hot flashes in men on ADT 1, 2
  • Cognitive behavioral therapy (CBT) has been shown to reduce the perceived burden of hot flashes in men on ADT 1, 2

REFERENCES

1

survivorship, version 2.2017, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2017

2

survivorship, version 2.2017, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2017

3

survivorship, version 2.2017, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2017